Phase 2 Study of the MEK inhibitor MEKTOVI (binimetinib) for the treatment of pediatric adamantinomatous craniopharyngioma

Is this Study for You?

Let's Get Started!

Details
Age

Child to Adult

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Kathleen Dorris

Kathleen Dorris

Study ID

Protocol Number: 22-2133

More information available at ClinicalTrials.gov: NCT05286788

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers